CytoReason vs Hims & Hers Health
CytoReason vs Hims & Hers Health, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CytoReason is on 68/100 and Hims & Hers Health on 58/100.
Where each one leads
CytoReason
- our overall score: 68/100 against 58/100
Hims & Hers Health
- agent readiness: 37/100 against 21/100
- domain rating: 79/100 against 40/100
- headcount: 1,000 against 116
- funding raised: $1.7B against $128M
At a glance
| Measure | CytoReason | Hims & Hers Health |
|---|---|---|
| What it is | Develops a computational model of the human body for drug discovery and development. | A telehealth company providing personalized healthcare for men and women. |
| Category | Healthcare, Drug Discovery, Clinical Development, Biomarkers | Healthcare, Telemedicine, E-commerce, Pharmaceuticals |
| Sells toBusiness model | B2B | B2C |
| Offering | Software | Services |
| Founded | 2016 | 2017 |
| Headquarters | Tel Aviv, Israel | San Francisco, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | CytoReason | Hims & Hers Health |
|---|---|---|
| Employees | 116 | 1,000 |
| Headcount growthLast 12 months | +13.7% | Not published |
| Total funding | $128M | $1.7B |
| Latest round | Series B | Convertible Senior Notes Offering |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 12,830 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CytoReason | Hims & Hers Health |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 68/100 | 58/100 |
| Traction | 60/100 | 60/100 |
| Team | 70/100 | Not published |
| Community | Not published | 15/100 |
| Search visibility | 30/100 | 17/100 |
| Quality | 78/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (37/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 79/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CytoReason | Hims & Hers Health |
|---|---|---|
| CDN | Not detected | Cloudflare |
| Analytics | Segment | Not detected |
| Support stack | Not detected | Zendesk |
CytoReason vs Hims & Hers Health: common questions
Which is better, CytoReason or Hims & Hers Health?
On our 0-100 score CytoReason rates higher (68/100 against 58/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do CytoReason and Hims & Hers Health compare on the numbers?
CytoReason leads on our overall score (68/100 against 58/100). Hims & Hers Health leads on agent readiness (37/100 against 21/100), domain rating (79/100 against 40/100), headcount (1,000 against 116), funding raised ($1.7B against $128M).
Read the full CytoReason review and pricing or the Hims & Hers Health review and pricing. You can also browse other CytoReason alternatives we track.